Therapeutic gas delivery device

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top, isometric view of a therapeutic gas delivery device, showing our new design, wherein oblique line shading indicates a transparent surface;

FIG. 2 is a front elevational view thereof, wherein oblique line shading indicates a transparent surface;

FIG. 3 is a rear elevational view thereof;

FIG. 4 is a right side elevational view thereof, wherein oblique line shading indicates a transparent surface;

FIG. 5 is a left side elevational view thereof, wherein oblique line shading indicates a transparent surface;

FIG. 6 is a top plan view thereof, wherein oblique line shading indicates a transparent surface; and,

FIG. 7 is a bottom plan view thereof.

The broken lines depict portions of the therapeutic gas delivery device which form no part of the claimed design.

Claims

The ornamental design for a therapeutic gas delivery device as shown and described.

Referenced Cited
U.S. Patent Documents
5558083 September 24, 1996 Bathe et al.
5732693 March 31, 1998 Bathe et al.
5752504 May 19, 1998 Bathe
5827950 October 27, 1998 Woodbury et al.
6089229 July 18, 2000 Bathe et al.
6125846 October 3, 2000 Bathe et al.
6164276 December 26, 2000 Bathe et al.
6543444 April 8, 2003 Lewis
D530854 October 24, 2006 Xu
7159608 January 9, 2007 Lucas, Jr. et al.
D549342 August 21, 2007 Ross
D590505 April 14, 2009 Mazoyer
7523752 April 28, 2009 Montgomery et al.
7768409 August 3, 2010 Parias
8282966 October 9, 2012 Baldassarre et al.
8291904 October 23, 2012 Bathe et al.
8293284 October 23, 2012 Baldassarre et al.
8366815 February 5, 2013 Taylor
8431163 April 30, 2013 Baldassarre et al.
8573209 November 5, 2013 Bathe et al.
8573210 November 5, 2013 Bathe et al.
D700701 March 4, 2014 Taylor
D701963 April 1, 2014 Abarbanel
8757148 June 24, 2014 Montgomery et al.
8776794 July 15, 2014 Bathe et al.
8776795 July 15, 2014 Bathe et al.
8795741 August 5, 2014 Baldassarre
8846112 September 30, 2014 Baldassarre
D729936 May 19, 2015 Reback
D729937 May 19, 2015 Acker
D730525 May 26, 2015 Acker
9816642 November 14, 2017 Fowler et al.
D808017 January 16, 2018 Ito
D861874 October 1, 2019 Hirano
D884187 May 12, 2020 Robert
10953187 March 23, 2021 Galbraith
D930835 September 14, 2021 Taylor
D1069120 April 1, 2025 Mao
20030189492 October 9, 2003 Harvie
20050004511 January 6, 2005 Figley et al.
20060283517 December 21, 2006 McCulloh et al.
20080150739 June 26, 2008 Gamard
20100003349 January 7, 2010 Miller
20100030917 February 4, 2010 Kaneko
20110140850 June 16, 2011 Wassel et al.
20120080103 April 5, 2012 Levine et al.
20120116292 May 10, 2012 Montgomery et al.
20120226451 September 6, 2012 Bacot et al.
20140048063 February 20, 2014 Bathe et al.
20140127081 May 8, 2014 Fine et al.
Foreign Patent Documents
202430301544.6 December 2024 CN
0659445 June 1995 EP
0960629 December 1999 EP
9844976 October 1998 WO
9922796 May 1999 WO
9959662 November 1999 WO
0195972 December 2001 WO
2008112423 September 2008 WO
2010044039 April 2010 WO
2011084538 July 2011 WO
2012094008 July 2012 WO
2013054217 April 2013 WO
2014144184 September 2014 WO
2016096056 June 2016 WO
Other references
  • Z&HA Oxygen Concentrator, Online, Published date Sep. 1, 2021, Retrieved on May 14, 2024 from URL: https://www.amazon.de/-/en/Portable-Concentrator-Intelligent-Adjustable-Humidifier/dp/B09F62Y5PT (Year: 2021).
  • Annex to Form PCT/ISA/206 Communication Related to the Results of the Partial International Search in PCT/US2015/030217, dated Aug. 4, 2015, 7 pages.
  • English Translation of Abstract of Japanese Application H09299485,1 page.
  • English Translation of Abstract of Japanese Application No. 2010508877A, 1 page.
  • European Search Report in European Application No. 19168698.9 dated Oct. 22, 2019, 16 pages.
  • Examination Report No. 1 for Australian Application No. 2022211800, mailed on Nov. 16, 2023, 4 pages.
  • Examination Report No. 1 for Australian Patent Application No. 2021204009 dated Mar. 16, 2022, 2 Pages.
  • Extended European Search Report for Application No. EP19168698.9, dated Jan. 24, 2020, 14 Pages.
  • Extended European Search Report for European Application No. 23215086.2, mailed on Feb. 12, 2024, 10 pages.
  • Final Office Action in U.S. Appl. No. 14/709,316, dated Sep. 5, 2018, 11 pages.
  • INOblender Operations Manual, Ikaria, Inc. 2010, 34 pages.
  • INOmax DS (Delivery System): Operation Manual (800 ppm INOmax (nitric oxide) for Inhalation), Ikaria, Inc. 2010, 112 pages.
  • INOmax DSIR (Delivery System): Operation Manual (800 ppm INOmax (nitric oxide) for Inhalation), Ikaria, Inc. 2012, 136 pages.
  • INOmax DS.sub.IR INOblender—Pre-Use Checkout, Ikaria, Inc. 2014, 2 pages.
  • INOmax Label, Nitric Oxide Gas, INO Therapeutics 2013, 2 pages.
  • INOvent Delivery System: Operation and Maintenance Manual (CGA Variant), Datex-Ohmeda, Inc. 2000, 180 pages.
  • International Preliminary Report on Patentability for International PCT Patent Application No. PCT/US2015/030217, mailed on Nov. 24, 2016, 17 pages.
  • International Search Report and Written Opinion in PCT/US2015/030217, dated Oct. 19, 2015, 23 pages.
  • Japanese Office Action in Japanese Application No. 2017-511572 dated Mar. 19, 2019, 8 pages.
  • Non-Final Office Action for U.S. Appl. No. 16/748,319 dated May 24, 2022, 18 pages.
  • Non-Final Office Action in U.S. Appl. No. 16/825,840 dated May 7, 2020, 11 pages.
  • Non-Final Office Action in U.S. Appl. No. 16/825,848 dated May 7, 2020, 8 pages.
  • Non-Final Office Action in U.S. Appl. No. 16/217,969, issued May 7, 2020, 8 pages.
  • Office Action dated May 3, 2021 for Canadian Patent Application No. 2941761, 5 Pages.
  • Office Action for Australian Application No. 2015255688 dated Jun. 7, 2019 , 5 pages.
  • Office Action for Canadian Application No. 2,941,761 mailed on Jul. 28, 2023, 4 pages.
  • Office Action for Canadian Application No. 3, 138,339, mailed on Jan. 17, 2023, 3 pages.
  • Office Action for Canadian Application No. 3,138,342 mailed on Nov. 7, 2023, 4 pages.
  • Office Action for Canadian Application No. 3,142,415, mailed on Jan. 18, 2023, 4 pages.
  • Office Action for Canadian Patent Application No. 2941761, mailed Feb. 11, 2022, 4 Pages.
  • Office Action for European Application No. 19168698.9, mailed on Oct. 14, 2022, 6 pages.
  • Office Action for Japanese Patent Application No. 2017511572, mailed Sep. 21, 2021, 6 Pages.
  • Office Action for Mexican Application No. MX/a/2021/007810 mailed on Jul. 15, 2022, 7 pages.
  • Office action for Mexican Application No. MX/a/2021/007814 dated Jun. 30, 2022, 9 pages.
  • Office Action for Mexican Application No. MX/a/2021/007816, mailed on Oct. 7, 2022, 6 pages.
  • Office action regarding U.S. Appl. No. 14/709,316 dated Feb. 1, 2018, 10 pages.
  • Office action regarding U.S. Appl. No. 14/709,316 dated Feb. 26, 2019, 11 pages.
  • Partial European Search Report for European Application No. 23215095.3, mailed on Feb. 12, 2024, 15 Pages.
  • Using the INOpulse DS Subject Guide, Ikaria, Inc. 2012, 50 pages.
  • Office Action dated Jul. 24, 2023 for New Zealand Patent Application No. 432323, 2 Pages.
Patent History
Patent number: D1108635
Type: Grant
Filed: Feb 14, 2023
Date of Patent: Jan 6, 2026
Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED (Dublin)
Inventors: Michael McAtamney (Navan), Jaron Matthew Acker (Madison, WI), Curtis Irwin (Madison, WI), Jake Martyn Goodwin (Shaftesbury)
Primary Examiner: Michael C Stout
Assistant Examiner: Eric Eldone Tormanen
Application Number: 29/884,630
Classifications
Current U.S. Class: Pulmonary (38) (D24/164)